Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
2007

Effectiveness of Polymyxin B-Immobilized Fiber Column in Sepsis

Sample size: 1425 publication 10 minutes Evidence: moderate

Author Information

Author(s): Cruz Dinna N, Perazella Mark A, Bellomo Rinaldo, Cal Massimo, Polanco Natalia, Corradi Valentina, Lentini Paolo, Nalesso Federico, Ueno Takuya, Ranieri V Marco, Ronco Claudio

Primary Institution: Ospedale San Bortolo, Vicenza, Italy

Hypothesis

Does direct hemoperfusion with Polymyxin B-immobilized fiber improve outcomes in septic patients?

Conclusion

Direct hemoperfusion with PMX-F appears to have favorable effects on blood pressure, use of vasoactive drugs, oxygenation, and mortality.

Supporting Evidence

  • Mean arterial pressure increased by 19 mm Hg after treatment.
  • Dopamine/dobutamine dose decreased by 1.8 μg/kg per minute.
  • PaO2/FiO2 ratio increased by 32 units.
  • PMX-F therapy was associated with a lower mortality risk (risk ratio, 0.53).

Takeaway

This study found that a special treatment using Polymyxin B can help sick patients with sepsis feel better and live longer.

Methodology

A systematic review of 28 studies including randomized controlled trials and observational studies.

Potential Biases

Publication bias and lack of blinding in studies may affect results.

Limitations

Overall study quality was suboptimal, and very few studies were designed to specifically assess mortality.

Participant Demographics

Patients included were aged 39 to 78.5 years, with a range of male percentages from 20% to 85.7%.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI, 15 to 22 mm Hg

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc5780

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication